source
- Merck, Gilead report mixed outcomes in key lung cancer, HIV studiesTrodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV tablet could boost Gilead's main business.
- Federal alcohol study finds low-level drinking may raise disease risk, faces political pushbackSTAT’s Morning Rounds reported that a federally commissioned study on alcohol’s health effects was published today in an independent journal. The researchers concluded that even modest alcohol cons…